VIN History USA’s ‘Free’ VIN Report
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
Ozempic, Wegovy, and Other GLP-1 RA Medications
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
Case Name (Date)
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Product/Service
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Allegations
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Status
Pending
The Latest
Will the MLM Industry Fix Its Earnings Claims Problem?
New research points to “no.”
TINA.org Supports Citizen Petition Calling for AI Pricing Transparency
Why disclosures are key to protecting informed consumer choice and competition.
James ‘Jay’ Noland’s Latest Ventures Raise Familiar Concerns
Permanently banned from MLM, Noland has found other ways to exploit consumers.
Broadway.com
Pulling back the curtain on this official-sounding website.